본문 바로가기

Data Plus(+)

All 807,818 Page 12,295/80,782

검색

Contents

No Journal_name Subject Date DOI Author
684878 CANCER MANAGEMENT AND RESEARCH The Clinical Significance and Biological Function of PCDH7 in Cervical Cancer 2021-05-01 10.2147/cmar.s298072 Zhang Shitong, Fu Xianhu
684877 CANCER MANAGEMENT AND RESEARCH Normal Basal Epithelial Cells Stimulate the Migration and Invasion of Prostate Cancer Cell RM-1 by TGF-β1/STAT3 Axis in vitro 2021-05-01 10.2147/cmar.s303122 Li Chun-Yan, Chen Chun-Ya, An Jian-Hong, Wu Jian-Bin, Shen Hong
684876 CANCER MANAGEMENT AND RESEARCH Prevalence of Medication Errors and the Associated Factors: A Prospective Observational Study Among Cancer Patients at Mbarara Regional Referral Hospital 2021-05-01 10.2147/cmar.s307001 Dorothy Abigaba, Yadesa Tadele Mekuriya, Atukunda Esther
684875 CANCER MANAGEMENT AND RESEARCH The Predominant Prognostic Significance of NOTCH1 Mutation Defined by Emulsion PCR in Chronic Lymphocytic Leukemia 2021-05-01 10.2147/cmar.s302245 Skórka Katarzyna, Chojnacki Michał, Masternak Marta, Karczmarczyk Agnieszka, Subocz Edyta, Wawrzyniak Ewa, Giannopoulos Krzysztof
684874 CANCER MANAGEMENT AND RESEARCH Recent Advances in the Potential Use of Circular RNA for the Diagnosis and Treatment of Pancreatic Cancer 2021-05-01 10.2147/cmar.s308809 Sun Xinzhu, Liu Dongyan, Ge Nan, Guo Jintao, Wang Sheng, Liu Xiang, Wang Guoxin, Sun Siyu
684873 CANCER MANAGEMENT AND RESEARCH circRNA-TBC1D4, circRNA-NAALAD2 and circRNA-TGFBR3: Selected Key circRNAs in Neuroblastoma and Their Associations with Clinical Features 2021-05-01 10.2147/cmar.s297316 Lin Weihong, Wang Zuopeng, Wang Jing, Yan Hanlei, Han Qilei, Yao Wei, Li Kai
684872 CANCER MANAGEMENT AND RESEARCH Cost-Effectiveness Analysis of Dacomitinib versus Gefitinib in the First-Line Treatment of EGFR-Positive Advanced or Metastatic Non-Small Cell Lung Cancer 2021-05-01 10.2147/cmar.s293983 Zhang Longfeng, Li Na, Liu Maobai, Zheng Bin, Wu Zhijuan, Cai Hongfu
684871 CANCER MANAGEMENT AND RESEARCH Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma 2021-05-01 10.2147/cmar.s309092 Lee Yong-Pyo, Hong Jung Yong, Yoon Sang Eun, Cho Junhun, Shim Joon-Ho, Bang Yeonghak, Kim Won Seog, Kim Seok Jin
684870 CANCER MANAGEMENT AND RESEARCH CircRNA circ_POLA2 is Upregulated in Acute Myeloid Leukemia (AML) and Promotes Cell Proliferation by Suppressing the Production of Mature miR-34a 2021-05-01 10.2147/cmar.s281690 Li Hong, Bi Kehong, Feng Saran, Wang Yan, Zhu Chuansheng
684869 CANCER MANAGEMENT AND RESEARCH MiR-139-5p Targetedly Regulates YAF2 and Mediates the AKT/P38 MAPK Signaling Pathway to Alleviate the Metastasis of Non-Small Cell Lung Cancer Cells and Their Resistance Against Cisplatin 2021-05-01 10.2147/cmar.s254671 Yan Yubo, Jin Xiangyuan, Sun HaoBo, Pang Sainan, Kong Xianglong, Bu Jianlong, Xu Shidong